Effect of environmental substances on the activity of arylamine N-Acetyltransferases

Current Drug Metabolism

Volumn 9, Issue 6, 2008, Pages 505-509

  Rodrigues Lima, Fernando ^a   Dairou, Julien ^a   Dupret, Jean Marie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Catalytic mechanism; Covalent modification; Inhibition; N acetyltransferases; Xenobiotics

Indexed keywords

11ALPHA HYDROXYCINNMOSMOLIDE; 4 AMINOBENZOIC ACID; 4 AMINOPHENOL; AMINOSALICYLIC ACID; ANTIMYCOBACTERIAL AGENT; ARYLAMINE ACETYLTRANSFERASE; ASCORBIC ACID; CISPLATIN; COUMARIN DERIVATIVE; DOXORUBICIN; DOXYCYCLINE; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN DERIVATIVE; FLAVONOID; FOLIC ACID; GENISTEIN; HYDRAZINE DERIVATIVE; ISONIAZID; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; POLYPHENOL DERIVATIVE; PROCAINAMIDE; RIFAMPICIN; SULFADIMIDINE; SULFAMETHOXAZOLE; TAMOXIFEN; XENOBIOTIC AGENT;

AGRANULOCYTOSIS; ANTIBIOTIC RESISTANCE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; DRUG ACETYLATION; DRUG ANTAGONISM; DRUG DETOXIFICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG TARGETING; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; REVIEW; UNSPECIFIED SIDE EFFECT;

ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; ENVIRONMENTAL POLLUTANTS; HUMANS; OXIDANTS;

EID: 47749149964     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008784892092     Document Type: Review

References (66)

1. Sim, E.; Westwood, I. and Fullam, E. (2007) Expert. Opin. Drug Metab. Toxicol., 3, 169-184.
2. Bönicke, R. and Reif, W. (1953) Arch. Exp. Pathol. Pharmakol., 220, 321-333.
3. Hein, D.; McQueen, C.; Grant, D.; Goodfellow, G.; Kadlubar, F. and Weber, W. (2000) Drug Metab. Dispos., 28, 1425-1432.
4. Boukouvala, S. and Fakis, G. (2005) Drug Metab. Rev., 37, 511-564.
5. Hein, D. W.; Doll, M. A.; Fretland, A. J.; Leff, M. A.; Webb, S. J.; Xiao, G. H.; Devanaboyina, U. S.; Nangju, N. A. and Feng, Y. (2000) Cancer Epidemiol. Biomarkers. Prev., 9, 29-42.
6. Hein, D. (2002) Mutat. Res., 65, 506-507.
7. Hein, D. W. (2006) Oncogene, 25, 1649-58.
8. Wu, H.; Dombrovsky, L.; Tempel, W.; Martin, F.; Loppnau, P.; Goodfellow, G. H.; Grant, D. M. and Plotnikov, A. N. (2007) J. Biol. Chem., 282, 30189-97.
9. Cornish, V.; Pinter, YL; Boukouvala, S.; Johnson, N.; Labrousse, C.; Payton, M.; Priddle, H.; Smith, A. J. H. and Sim, E. (2003) Pharmacogenomics. J., 3, 169-177.
10. Sugamori, K. S.; Wong, S.; Gaedigk, A.; Yu, V.; Abramovici, H.; Rozmahel, R. and Grant, D. M. (2003) Mol. Pharmacol., 64, 170-9.
11. Cao, W.; Chau, B.; Hunter, R.; Stmatka, D.; McQueen, C. A. and Erickson, R. P. (2005) Pharmacogenomics. J., 5, 255-61.
12. Minchin, R. F. (1995) Biochem. J., 307, 1-3.
13. Minchin, R. F.; Hanna, P. E.; Dupret, J. M.; Wagner, C. R.; Rodrigues-Lima, F. and Butcher, N. J, (2007) Int. J. Biochem. Cell. Biol., 39, 1999-2005.
14. Wakefield, L.; Cornish, V.; Long, H.; Griffiths, W. J. and Sim, E. (2007) Biochem. Biophys. Res. Commun., 364, 556-60.
15. Rodrigues-Lima, F.; Cooper, R.; Goudeau, B.; Atmane, N.; Chamagne, A.; Butler-growne, G.; Sim, E.; Vicart, P. and Dupret, J. (2003) J. Histochem. Cytochem., 51, 789-796.
16. Meisel, P. (2002) Pharmacogenomics, 3, 349-66.
17. Kawakubo, Y.; Merk, H. F.; Al Masaoudi, T.; Sieben, S. and Blomeke, B. (2000) J. Pharm. Exp. Ther., 292, 150-155.
18. Butcher, N. J.; Ilett, K. F. and Minchin, R. F. (2000), Biochem. Pharmacol., 60, 1829-36.
19. Butcher, N. J.; Ilett, K. F. and Minchin, R. F. (2000) Mol. Pharmacol., 57, 468-73.
20. Guo, Z.; Wagner, C. R. and Hanna, P. E. (2004) Chem. Res. Toxicol., 17, 275-86.
21. Wang, H.; Wagner, C. R. and Hanna, P. E. (2005) Chem. Res. Toxicol., 18, 183-197.
22. Guo, Z.; Vath, G. M.; Wagner, C. R. and Hanna, P. E. (2003) J. Protein Chem., 22, 631-42.
23. Cullen, K. J.; Yang, Z.; Schumaker, L. and Guo, Z. (2007) J. Bioenerg. Biomembr., 39, 43-50.
24. Hasinoff, B. B.; Wu, X.; Krokhin, O. V.; Ens, W.; Standing, K. G.; Nitiss, J. L.; Sivaram, T.; Giorgianni, A.; Yang, S.; Jiang, Y. and Yalowich, J. C. (2005) Mol. Pharmacol., 67, 937-47.
25. Ragunathan, N.; Dairou, J.; Pluvinage, B.; Martins, M.; Petit, E.; Janel, N.; Dupret, J. M. and Rodrigues-Lima, F. (2008) Mol. Pharmacol., 73, 1761-8.
26. Wakefield, L.; Robinson, J.; Long, H.; Ibbitt, J. C.; Cooke, S.; Hurst, H. C. and Sim, E. (2008) Genes Chromosomes Cancer, 47, 118-26.
27. Kawamura, A.; Westwood, I.; Wakefield, L.; Long, H.; Zhang, N.; Walters K.; Redfield, C. and Sim, E. (2008) Biochem. Pharmacol., 75, 1550-60.
28. Lee, J. H.; Lu, H. F.; Wang, D. Y.; Chen, D. R.; Su, C. C.; Chen, Y. S.; Yang, J. H. and Chung, J. G. (2004) Res. Commun. Mol. Pathol. Pharmacol., 115, 116, 217-33.
29. Adam, P. J.; Berry, J.; Loader, J. A.; Tyson, K., L.; Craggs, G.; Smith, P.; De Belin, J.; Steers, G.; Pezzella, F.; Sachsenmeir, K. F.; Stamps, A. C:; Herath, A.; Sim, E.; O'Hare, M. J.; Harris, A. L. and Terrett, J. A. (2003) Mol. Cancer Res., 1, 826-835.
30. Rothen, J. P.; Haefeli, W. E.; Meyer, U. A.; Todesco, L. and Wenk, M. (1998) Pharmacogenetics, 8, 553-559.
31. Dressler, W. E. and Appelqvist, T. (2006) Food Chem. Toxicol., 44, 371-9.
32. Zysset, T. and Peretti, E. (1986) Eur. J. Clin. Pharmacol., 30, 463-6.
33. Crook, J. E.; Woosley, R. L.; Leftwich, R. B. and Natelson, E. A. (1979) South. Med. J., 72, 1599-601.
34. Colmenero, J. D.; Fernandez-Gallardo, L. C.; Agundez, J. A.; Sedeno, J.; Benitez, J. and Valverde, E. (1994) Antimicrob. Agents Chemother., 38, 2798-802.
35. Kukongviriyapan, V.; Phromsopha, N.; Tassaneeyakul, W.; Kukongviriyapan, U.; Sripa, B.; Hahnvajanawong, V. and Bhudhisawasdi, V. (2006) Xenobiotica, 36, 15-28.
36. Lancon, A.; Hanet, N.; Jannin, B.; Delmas, D.; Heydel, J. M.; Lizard, G.; Chagnon, M. C.; Artur, Y. and Latruffe, N. (2007) Drug Metab. Dispos., 35, 699-703.
37. Wu, H. C.; Lu, H. F.; Hung, C. F. and Chung, J. G. (2000) Urol. Res., 28, 235-40.
38. Deloménie, C.; Fouix, S.; Longuemaux, S.; Brahimi, N.; Bizet, C.; Picard, B.; Denamur, E. and Dupret, J. M. (2001) J. Bacteriol., 183, 3417-27.
39. Rodrigues-Lima, F.; Dairou, J.; Diaz, C. L.; Rubio, M. C.; Sim, E.; Spaink, H. P. and Dupret, J. M. (2006) Mol. Microbiol., 60, 505-12.
40. Pluvinage, B.; Dairou, J.; Possot, O. M.; Martins, M.; Fouet, A.; Dupret, J. M. and Rodrigues-Lima, F. (2007) Biochemistry, 46, 7069-78.
41. Payton, M.; Auty, R.; Delgoda, R.; Everett, M. and Sim, E. (1999) J. Bacteriol., 181, 1343-7.
42. Chen, G. W.; Chung, J. G.; Ho, H. C. and Lin, J. G. (1999) J. Appl. Toxicol., 19, 75-81.
43. Lu, H. F.; Tsou, M. F.; Lin, J. G.; Ho, C. C.; Liu, J. Y.; Chuang, J. Y. and Chung, J. G. (2005) In Vivo, 19, 195-9.
44. Madikane, V. E.; Bhakta, S.; Russell, A. J.; Campbell, W. E.; Claridge, T. D.; Elisha, B. G.; Davies, S. G.; Smith, P. and Sim, E. (2007) Bioorg. Med. Chem., 15, 3579-86.
45. Boelsterli, U. Mechanistic toxicology. The molecular basis of how chemicals disrupt biological targets, Taylor and Francis Group, London and New-York 2003.
46. Barouki, R. and Morel, Y. (2001) Biochem. Pharmacol., 61, 511-6.
47. Kohle, C. and Bock, K. W. (2007) Biochem. Pharmacol., 73, 1853-62.
48. Atmane, N.; Dairou, J.; Paul, A.; Dupret, J. M. and Rodrigues-Lima, F. (2003) J. Biol. Chem., 278, 35086-92.
49. Dairou, J.; Atmane, N.; Dupret, J. M. and Rodrigues-Lima, F. (2003) Biochem. Biophys. Res. Commum., 307, 1059-65.
50. Dairou, J.; Atmane, N.; Rodrigues-Lima, F. and Dupret, J. M. (2004) J. Biol. Chem., 279, 7708-7714.
51. Dairou, J.; Dupret, J. M. and Rodrigues-Lima, F. (2005) FEBS. Lett., 579, 4719-23.
52. Dairou, J.; Malecaze, F.; Dupret, J. M. and Rodrigues-Lima, F. (2005) Mol. Pharmacol., 67, 1299-1306.
53. Dupret, J. M. and Rodrigues-Lima, F. (2005) Curr. Med. Chem., 12, 311-318.
54. Dupret, J. M.; Dairou, J.; Atmane, N. and Rodrigues-Lima, F. (2005) Methods. Enzymol., 400, 215-29.
55. Wong, P.; Eiserich, J.; Reddy, S.; Lopez, C.; Cross, C. and van der Vliet, A. (2001) Arch. Biochem. Biophys., 394, 216-228.
56. Maiti, S. and Zhang, J.; Chen, G. (2007) Biochem. Pharmacol., 73, 1474-81.
57. Lacour, S.; Gautier, J. C.; Pallardy, M. and Roberts, R. (2005) Cancer Biomark., 1, 29-39.
58. Buranrat, B.; Prawan, A.; Sripa, B. and Kukongviriyapan, V. (2007) World J. Gastroenterol., 13, 6219-25.
59. Butcher, N. J.; Tetlow, N. L.; Cheung, C.; Broadhurst, G. M. and Minchin, R. F. (2007) Cancer Res., 67, 85-92.
60. Chen, J.; Ahn, K. C.; Gee, N. A,; Ahmed, M. I.; Duleba, A. J.; Zhao, L.; Gee, S. J.; Hammock B. D. and Lasley, B. L. (2008) Endocrinology, 149, 1173-9.
61. Butcher, N. J.; Arulpragasam, A.; Pope, C. and Minchin, R. F. (2003) Biochem. J., 376, 441-8.
62. Mitchell, K. R. and Warshawsky, D. (2003) Toxicol. Lett., 139, 11-23.
63. Husain, A.; Barker, D. F.; States, J. C.; Doll, M. A. and Hein, D. W. (2004) Pharmacogenetics, 14, 397-406.
64. Husain, A.; Zhang, X; Doll, M. A.; States, J. C.; Barker, D. F.; Hein, D. W. (2007) Drug Metab. Dispos., 35, 1649-56.
65. Husain, A.; Zhang, X.; Doll, M. A.; States, J. C.; Barker, D. F. and Hein, D. W. (2007) Drug Metab. Dispos., 35, 721-7.
66. Butcher, N. J.; Arulpragasam, A. and Minchin, R. F. (2004) J. Biol. Chem., 279, 22131-7.